Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancer
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 215, Issue 6, Pages 1693-1708
Publisher
Rockefeller University Press
Online
2018-05-16
DOI
10.1084/jem.20171455
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
- (2017) Yuji Miyamoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Visualization and targeting of LGR5+ human colon cancer stem cells
- (2017) Mariko Shimokawa et al. NATURE
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Metastatic colonization by circulating tumour cells
- (2016) Joan Massagué et al. NATURE
- HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer
- (2015) Ruixue Yuan et al. CLINICAL & EXPERIMENTAL METASTASIS
- Notch-1 Promotes Stemness and Epithelial to Mesenchymal Transition in Colorectal Cancer
- (2015) Alexander W. Fender et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
- (2014) J. Y. Douillard et al. ANNALS OF ONCOLOGY
- Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression
- (2014) L Bakiri et al. CELL DEATH AND DIFFERENTIATION
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
- (2014) Volker Heinemann et al. LANCET ONCOLOGY
- A new tumor suppressor role for the Notch pathway in bladder cancer
- (2014) Theodoros Rampias et al. NATURE MEDICINE
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Colorectal Cancers Mimic Structural Organization of Normal Colonic Crypts
- (2014) Laura Cernat et al. PLoS One
- A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells
- (2013) Pengcheng Bu et al. Cell Stem Cell
- Differential WNT Activity in Colorectal Cancer Confers Limited Tumorigenic Potential and Is Regulated by MAPK Signaling
- (2012) D. Horst et al. CANCER RESEARCH
- A phase II study of RO4929097 in metastatic colorectal cancer
- (2012) Jonathan R. Strosberg et al. EUROPEAN JOURNAL OF CANCER
- Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer
- (2012) Hyun-A Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
- (2012) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Suppression of Colon Cancer Metastasis by Aes through Inhibition of Notch Signaling
- (2011) Masahiro Sonoshita et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells
- (2011) Simone Brabletz et al. EMBO JOURNAL
- The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice
- (2011) Yanan Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- -catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness
- (2011) E. Sanchez-Tillo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens
- (2010) Jaafar Bennouna et al. INVESTIGATIONAL NEW DRUGS
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Constitutively active MEK1 is sufficient to induce epithelial-to-mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis
- (2009) Étienne Lemieux et al. INTERNATIONAL JOURNAL OF CANCER
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells
- (2009) Liyun Sang et al. TRENDS IN MOLECULAR MEDICINE
- Notch signaling mediates hypoxia-induced tumor cell migration and invasion
- (2008) C. Sahlgren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search